InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Adamchak Mark. Director active across 1 company, notably Bionano Genomics, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 15 February 2025. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Adamchak Mark is a declarant connected to Bionano Genomics, Inc. as Principal Accounting Officer. The record shows 4 filings in total, and the sampled recent filings cover the period from 2025-02-19 to 2026-06-03, with transaction nature shown as tax withholding.